The Islamic Legal Status of Medicines Containing Impure (Najis) Ingredients: An Analytical & Comparative Study in the Light of Selected Juristic Exegeses of the Holy Qur'an (Tafāsīr Aḥkām al-Qurʾān)

نجس اجزاء پر مشتمل ادویات کی شرعی حیثیت : منتخب تفاسیر احکام القرآن کی روشنی میں تجزیاتی و تقابلی مطالعہ

Authors

  • M Akram ul haque Govt Graduate College Gulberg, Lahore: Lecturer, Department of Islamic Studies
  • Dr. Hafiz Muhammad Arshad Iqbal Assistant Professor, Faculty of Arabic & Islamic Studies ,Allama Iqbal Open University, Islamabad

DOI:

https://doi.org/10.67101/alamir.v6i03.268

Keywords:

Islamic Medical Ethics, Halal Pharmaceuticals, Impurity (Najāsah) in Shariah, Istihālah (Transformation), Principle of Necessity (Ḍarūrah), Comparative Fiqh

Abstract

This research paper examines the Shariah status of the use of impure and forbidden ingredients in modern pharmaceuticals. This research is based on the principles of the Qur'an's prohibition and has been argued by selected exegesis of the Ahkam al-Qur'an. The paper attempts to provide a solution to this complex problem by adopting exegetical, jurisprudential, comparative and analytical research. Key topics of research include the importance of treatment in Islam, the concept of impurity, and the Shariah rules for the use of medicines. The main point of the paper is the application of two important jurisprudential rules–Transformation/Metamorphosis (i.e. the complete change in the nature of the impure substance) and Necessity/Compulsion (permission to use haram in a state of severe compulsion) – to modern pharmaceutical products. In this study, a comparative analysis of the opinions of the Hanafi, Maliki, Shafi'i and Hanbali schools of jurisprudence has been presented and it has been made clear that although the use of medicines containing impure ingredients is forbidden under normal circumstances, in the case of metabolism, when the impure ingredient loses its original nature and is transformed into a new and pure substance, its use becomes permissible. Similarly, when there is a serious threat to the life or health of a patient and there is no halal alternative medicine available, there is a provision for the use of such medicine as required under the Emergency Rule. The paper also presents practical recommendations in the light of the fatwas of the international jurisprudential academies, emphasizing the establishment of international standards for the certification of halal medicines, encouraging pharmaceutical companies to develop halal alternatives, and discharging their responsibilities to Muslim patients and doctors in this regard. The essence of the research is that the principles of Islamic Shariah have the potential to address modern medical challenges, provided they are applied in depth and with insight.

Views & Downloads Stats:

Stats are being updated.

References

Muḥammad ibn ʿĪsā al-Tirmidhī, Al-Jāmiʿ al-Tirmidhī (Beirut: Dār al-Gharb al-Islāmī, 1998), Kitāb al-Ṭibb ʿan Rasūl Allāh, Bāb Mā Jāʾa fī al-Dawāʾ wa-l-Ḥathth ʿAlayh, ḥadīth no. 2038, 38–42.

Al-Qurʾān 38:42.

Aḥmad ibn ʿAlī al-Rāzī al-Jaṣṣāṣ, Aḥkām al-Qurʾān (Beirut: Dār Iḥyāʾ al-Turāth al-ʿArabī, 1412 AH/1992), 3:388.

Muḥammad ibn Aḥmad al-Qurṭubī, Al-Jāmiʿ li-Aḥkām al-Qurʾān (Cairo: Dār al-Kutub al-Miṣriyyah, 1384 AH/1964), 15:209.

Al-Qurʾān 16:69.

Muḥammad ibn Aḥmad al-Qurṭubī, Al-Jāmiʿ li-Aḥkām al-Qurʾān (Cairo: Dār al-Kutub al-Miṣriyyah), 6:85–95.

Muḥammad ibn Aḥmad al-Qurṭubī, Al-Jāmiʿ li-Aḥkām al-Qurʾān (Cairo: Dār al-Kutub al-Miṣriyyah), 2:221.

Aḥmad ibn ʿAlī al-Rāzī al-Jaṣṣāṣ, Aḥkām al-Qurʾān (Beirut: Dār Iḥyāʾ al-Turāth al-ʿArabī), 1:159.

Al-Qurʾān 2:172.

Al-Qurʾān 2:173.

Abū Bakr Aḥmad ibn ʿAlī al-Rāzī al-Jaṣṣāṣ, Aḥkām al-Qurʾān (Beirut: Dār Iḥyāʾ al-Turāth al-ʿArabī), 1:160.

Al-Qurʾān 2:172.

Abū Bakr Muḥammad ibn ʿAbd Allāh Ibn al-ʿArabī, Aḥkām al-Qurʾān (Beirut: Dār al-Kutub al-ʿIlmiyyah, n.d.), 1:118.

Abū ʿAbd Allāh Muḥammad ibn Aḥmad al-Qurṭubī, Al-Jāmiʿ li-Aḥkām al-Qurʾān (Cairo: Dār al-Kutub al-Miṣriyyah), 2:229.

Abū Bakr Aḥmad ibn ʿAlī al-Rāzī al-Jaṣṣāṣ, Aḥkām al-Qurʾān (Beirut: Dār Iḥyāʾ al-Turāth al-ʿArabī), 1:350.

Abū Bakr Aḥmad ibn ʿAlī al-Rāzī al-Jaṣṣāṣ, Aḥkām al-Qurʾān (Beirut: Dār Iḥyāʾ al-Turāth al-ʿArabī), 1:168.

Abū Bakr Muḥammad ibn ʿAbd Allāh Ibn al-ʿArabī, Aḥkām al-Qurʾān (Beirut: Dār al-Kutub al-ʿIlmiyyah, n.d.), 1:118.

ʿAlī ibn Muḥammad ibn ʿAlī al-Ṭabarī Kiyā al-Harāsī, Aḥkām al-Qurʾān (Beirut: Dār al-Kutub al-ʿIlmiyyah, 1403 AH), 1:39.

Mujīr al-Dīn ibn Muḥammad al-ʿAlīmī, Fatḥ al-Raḥmān fī Tafsīr al-Qurʾān (Beirut: Dār al-Nawādir, 1430 AH), 1:174.

Abū Bakr Aḥmad ibn ʿAlī al-Rāzī al-Jaṣṣāṣ, Aḥkām al-Qurʾān (Beirut: Dār Iḥyāʾ al-Turāth al-ʿArabī), 3:389.

Abū Jaʿfar Aḥmad ibn Muḥammad ibn Salāmah al-Azdī al-Ṭaḥāwī, Aḥkām al-Qurʾān li-l-Ṭaḥāwī (Beirut: Dār al-Kutub al-ʿIlmiyyah, 1411 AH), 2:246.

Islamic Fiqh Academy, Resolution no. 89 (8), “Istikhdām al-Jilātīn fī al-Ṣināʿāt al-Dawāʾiyyah wa-l-Ghidhāʾiyyah.”

Abū Bakr Aḥmad ibn ʿAlī al-Rāzī al-Jaṣṣāṣ, Aḥkām al-Qurʾān (Beirut: Dār Iḥyāʾ al-Turāth al-ʿArabī), 3:412.

Abū Bakr Muḥammad ibn ʿAbd Allāh Ibn al-ʿArabī, Aḥkām al-Qurʾān (Beirut: Dār al-Kutub al-ʿIlmiyyah, n.d.), 1:118.

Abū ʿAbd Allāh Muḥammad ibn Aḥmad al-Qurṭubī, Al-Jāmiʿ li-Aḥkām al-Qurʾān (Cairo: Dār al-Kutub al-Miṣriyyah), 3:249.

Raymond C. Rowe, Paul J. Sheskey, and Marian E. Quinn, eds., Handbook of Pharmaceutical Excipients, 6th ed. (London: Pharmaceutical Press, 2009).

Albert L. Lehninger, David L. Nelson, and Michael M. Cox, Lehninger Principles of Biochemistry, 7th ed. (New York: W.H. Freeman, 2017).

Fridrun Podczeck and Brian E. Jones, eds., Pharmaceutical Capsules, 2nd ed. (London: Pharmaceutical Press, 2004).

Al-Qurʾān 5:90.

Abū ʿAbd Allāh Muḥammad ibn Aḥmad al-Qurṭubī, Al-Jāmiʿ li-Aḥkām al-Qurʾān (Cairo: Dār al-Kutub al-Miṣriyyah), 8:53.

Michael Bliss, The Discovery of Insulin (Chicago: University of Chicago Press, 2007).

Glyn N. Stacey and John Davis, eds., Medicines from Animal Cell Culture (Chichester, West Sussex: John Wiley & Sons, 2007).

Abū Bakr Muḥammad ibn ʿAbd Allāh Ibn al-ʿArabī, Aḥkām al-Qurʾān (Beirut: Dār al-Kutub al-ʿIlmiyyah, n.d.), 1:118.

Christopher D. Hillyer, Blood Banking and Transfusion Medicine: Basic Principles and Practice, 2nd ed. (Philadelphia: Elsevier, 2007).

Raymond C. Rowe, Paul J. Sheskey, and Marian E. Quinn, eds., Handbook of Pharmaceutical Excipients, 6th ed. (London: Pharmaceutical Press, 2009).

Islamic Fiqh Academy, Resolution no. 91 (8/9), “Istikhdām al-Jilātīn fī al-Ṣināʿāt al-Dawāʾiyyah wa-l-Ghidhāʾiyyah,” 1995.

Downloads

Published

2025-11-25

How to Cite

M Akram ul haque, & Dr. Hafiz Muhammad Arshad Iqbal. (2025). The Islamic Legal Status of Medicines Containing Impure (Najis) Ingredients: An Analytical & Comparative Study in the Light of Selected Juristic Exegeses of the Holy Qur’an (Tafāsīr Aḥkām al-Qurʾān): نجس اجزاء پر مشتمل ادویات کی شرعی حیثیت : منتخب تفاسیر احکام القرآن کی روشنی میں تجزیاتی و تقابلی مطالعہ. Al-Amīr Research Journal for Islamic Studies, 6(03), 108–122. https://doi.org/10.67101/alamir.v6i03.268